Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ischemic Heart Disease

  Free Subscription


Articles published in Prog Cardiovasc Dis

Retrieve available abstracts of 80 articles:
HTML format



Single Articles


    March 2021
  1. PATEL RAG, White CJ
    Brachiocephalic and subclavian stenosis: Current concepts for cardiovascular specialists.
    Prog Cardiovasc Dis. 2021 Mar 17. pii: S0033-0620(21)00032.
    PubMed     Abstract available


    February 2021
  2. KRITTANAWONG C, Mahtta D, Narasimhan B, Wang Z, et al
    Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study.
    Prog Cardiovasc Dis. 2021 Feb 2. pii: S0033-0620(21)00015.
    PubMed    


    January 2021
  3. NARASIMHAN B, Kaplin SL, Narasimhan H, Wang Z, et al
    Trends in pneumococcal vaccination in patients presenting with acute coronary syndrome in the United States.
    Prog Cardiovasc Dis. 2021 Jan 9. pii: S0033-0620(21)00002.
    PubMed    


  4. LAVIE CJ
    Editor-in-chief eight years at Progress in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2021;64:138-139.
    PubMed    


    December 2020
  5. WILLIAMSON TM, Moran C, McLennan A, Seidel S, et al
    Promoting adherence to physical activity among individuals with cardiovascular disease using behavioral counseling: A theory and research-based primer for health care professionals.
    Prog Cardiovasc Dis. 2020 Dec 29. pii: S0033-0620(20)30209.
    PubMed     Abstract available


    November 2020
  6. MEHTA A, Kondamudi N, Laukkanen JA, Wisloff U, et al
    Running away from cardiovascular disease at the right speed: The impact of aerobic physical activity and cardiorespiratory fitness on cardiovascular disease risk and associated subclinical phenotypes.
    Prog Cardiovasc Dis. 2020 Nov 12. pii: S0033-0620(20)30184.
    PubMed     Abstract available


  7. CASTAGNA C, Krustrup P, Povoas S
    Cardiovascular fitness and health effects of various types of team sports for adult and elderly inactive individuals - a brief narrative review.
    Prog Cardiovasc Dis. 2020;63:709-722.
    PubMed     Abstract available


    September 2020
  8. LETNES JM, Dalen H, Aspenes ST, Salvesen O, et al
    Age-related change in peak oxygen uptake and change of cardiovascular risk factors. The HUNT study.
    Prog Cardiovasc Dis. 2020 Sep 21. pii: S0033-0620(20)30159.
    PubMed     Abstract available


  9. TEHRANI BN, Basir MB, Kapur NK
    Acute myocardial infarction and cardiogenic shock: Should we unload the ventricle before percutaneous coronary intervention?
    Prog Cardiovasc Dis. 2020 Sep 10. pii: S0033-0620(20)30157.
    PubMed     Abstract available


    August 2020
  10. UTH J, Fristrup B, Sorensen V, Helge EW, et al
    Exercise intensity and cardiovascular health outcomes after 12months of football fitness training in women treated for stage I-III breast cancer: Results from the football fitness After Breast Cancer (ABC) randomized controlled trial.
    Prog Cardiovasc Dis. 2020 Aug 12. pii: S0033-0620(20)30154.
    PubMed     Abstract available


    July 2020
  11. LAVIE CJ
    Statistics 2020 at progress in cardiovascular diseases.
    Prog Cardiovasc Dis. 2020 Jul 30. pii: S0033-0620(20)30145.
    PubMed    


  12. SEABRA A, Brito J, Figueiredo P, Beirao L, et al
    School-based soccer practice is an effective strategy to improve cardiovascular and metabolic risk factors in overweight children.
    Prog Cardiovasc Dis. 2020 Jul 25. pii: S0033-0620(20)30144.
    PubMed     Abstract available


  13. FREUND A, Desch S, Thiele H
    Intra-aortic balloon counterpulsation - Does it work?
    Prog Cardiovasc Dis. 2020 Jul 5. pii: S0033-0620(20)30138.
    PubMed     Abstract available


    June 2020
  14. LARSEN MN, Madsen M, Nielsen CM, Manniche V, et al
    Cardiovascular adaptations after 10months of daily 12-min bouts of intense school-based physical training for 8-10-year-old children.
    Prog Cardiovasc Dis. 2020 Jun 1. pii: S0033-0620(20)30119.
    PubMed     Abstract available


    May 2020
  15. YOUSUF T, Nakhle A, Rawal H, Harrison D, et al
    Natural disasters and acute myocardial infarction.
    Prog Cardiovasc Dis. 2020 May 14. pii: S0033-0620(20)30099.
    PubMed     Abstract available


  16. DESAI AS, Kamdar BB, Mehra MR
    Palliative care considerations for cardiovascular clinicians in COVID-19.
    Prog Cardiovasc Dis. 2020 May 8. pii: S0033-0620(20)30098.
    PubMed    


  17. KRITTANAWONG C, Virk HUH, Narasimhan B, Wang Z, et al
    Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis.
    Prog Cardiovasc Dis. 2020 May 7. pii: S0033-0620(20)30097.
    PubMed    


  18. LIPPI G, Lavie CJ, Sanchis-Gomar F
    Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis.
    Prog Cardiovasc Dis. 2020;63:390-391.
    PubMed    


    April 2020
  19. ZHOU K, Yang S, Jia P
    Towards precision management of cardiovascular patients with COVID-19 to reduce mortality.
    Prog Cardiovasc Dis. 2020 Apr 27. pii: S0033-0620(20)30084.
    PubMed    


  20. SANTOS HO, Earnest CP, Tinsley GM, Izidoro LFM, et al
    Small dense low-density lipoprotein-cholesterol (sdLDL-C): Analysis, effects on cardiovascular endpoints and dietary strategies.
    Prog Cardiovasc Dis. 2020 Apr 27. pii: S0033-0620(20)30081.
    PubMed     Abstract available


  21. KARIO K, Ferdinand KC, O'Keefe JH
    Control of 24-hour blood pressure with SGLT2 inhibitors to prevent cardiovascular disease.
    Prog Cardiovasc Dis. 2020 Apr 7. pii: S0033-0620(20)30074.
    PubMed     Abstract available


  22. GARG A, Rout A, Sharma A, Sargsyan D, et al
    Safety and efficacy of antiplatelet regimens after percutaneous coronary intervention using drug eluting stents: A network meta-analysis of randomized controlled trials.
    Prog Cardiovasc Dis. 2020 Apr 2. pii: S0033-0620(20)30072.
    PubMed     Abstract available


    March 2020
  23. DAS A, Roy B, Bandyopadhyay D, Dasgupta S, et al
    Non-statin interventions in the prevention of cardiovascular events: Sex-based meta-analysis.
    Prog Cardiovasc Dis. 2020 Mar 26. pii: S0033-0620(20)30064.
    PubMed     Abstract available


  24. LAVIE CJ
    Special assorted cardiovascular topics.
    Prog Cardiovasc Dis. 2020 Mar 26. pii: S0033-0620(20)30070.
    PubMed    


  25. GERSH F
    Benefits of estrogen in cardiovascular diseases.
    Prog Cardiovasc Dis. 2020 Mar 21. pii: S0033-0620(20)30062.
    PubMed    


  26. XU B, Kocyigit D, Griffin BP, Cheng F, et al
    Applications of artificial intelligence in multimodality cardiovascular imaging: A state-of-the-art review.
    Prog Cardiovasc Dis. 2020 Mar 19. pii: S0033-0620(20)30060.
    PubMed     Abstract available


  27. GULLO AL, Rodriguez-Carrio J, Gallizzi R, Imbalzano E, et al
    Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients.
    Prog Cardiovasc Dis. 2020 Mar 19. pii: S0033-0620(20)30057.
    PubMed     Abstract available


    February 2020
  28. HAMILTON AB, Brown A, Loeb T, Chin D, et al
    Enhancing patient and organizational readiness for cardiovascular risk reduction among black and Latinx patients living with HIV: Study protocol.
    Prog Cardiovasc Dis. 2020 Feb 25. pii: S0033-0620(20)30054.
    PubMed     Abstract available


  29. AIFAH A, Okeke NL, Rentrope CR, Schexnayder J, et al
    Use of a human-centered design approach to adapt a nurse-led cardiovascular disease prevention intervention in HIV clinics.
    Prog Cardiovasc Dis. 2020 Feb 21. pii: S0033-0620(20)30053.
    PubMed     Abstract available


  30. LONGENECKER CT, Webel AR, Lloyd-Jones DM
    Prevention as treatment: A bold vision for improving the cardiovascular health of people living with HIV.
    Prog Cardiovasc Dis. 2020 Feb 20. pii: S0033-0620(20)30051.
    PubMed    


  31. TAKADA S, Ober AJ, Currier JS, Goldstein NJ, et al
    Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial.
    Prog Cardiovasc Dis. 2020 Feb 18. pii: S0033-0620(20)30052.
    PubMed     Abstract available


  32. MANGIACAPRA F, Del Buono MG, Abbate A, Gori T, et al
    Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from pathophysiology to optimize treatment.
    Prog Cardiovasc Dis. 2020 Feb 13. pii: S0033-0620(20)30039.
    PubMed     Abstract available


  33. MUIRURI C, Longenecker CT, Meissner EG, Okeke NL, et al
    Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature.
    Prog Cardiovasc Dis. 2020 Feb 11. pii: S0033-0620(20)30036.
    PubMed     Abstract available


  34. OKELLO S, Amir A, Bloomfield GS, Kentoffio K, et al
    Prevention of cardiovascular disease among people living with HIV in sub-Saharan Africa.
    Prog Cardiovasc Dis. 2020 Feb 5. pii: S0033-0620(20)30034.
    PubMed     Abstract available


  35. WILLIAMS SK, Johnson BA, Tobin JN, Luque AE, et al
    Protocol paper: Stepped wedge cluster randomized trial translating the ABCS into optimizing cardiovascular care for people living with HIV.
    Prog Cardiovasc Dis. 2020 Feb 5. pii: S0033-0620(20)30033.
    PubMed     Abstract available


    January 2020
  36. OZEMEK C, Erlandson KM, Jankowski CM
    Physical activity and exercise to improve cardiovascular health for adults living with HIV.
    Prog Cardiovasc Dis. 2020 Jan 31. pii: S0033-0620(20)30027.
    PubMed     Abstract available


    November 2019
  37. MARTINEZ-GOMEZ D, Lavie CJ, Hamer M, Cabanas-Sanchez V, et al
    Physical activity without weight loss reduces the development of cardiovascular disease risk factors - a prospective cohort study of more than one hundred thousand adults.
    Prog Cardiovasc Dis. 2019 Nov 20. pii: S0033-0620(19)30144.
    PubMed     Abstract available


  38. DZAYE O, Dudum R, Reiter-Brennan C, Kianoush S, et al
    Coronary artery calcium scoring for individualized cardiovascular risk estimation in important patient subpopulations after the 2019 AHA/ACC primary prevention guidelines.
    Prog Cardiovasc Dis. 2019 Nov 9. pii: S0033-0620(19)30132.
    PubMed     Abstract available


    October 2019
  39. MINAME MH, Santos RD
    Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.
    Prog Cardiovasc Dis. 2019 Oct 25. pii: S0033-0620(19)30128.
    PubMed     Abstract available


    September 2019
  40. LAUKKANEN JA, Kunutsor SK, Ozemek C, Makikallio T, et al
    Cross-country skiing and running's association with cardiovascular events and all-cause mortality: A review of the evidence.
    Prog Cardiovasc Dis. 2019 Sep 7. pii: S0033-0620(19)30110.
    PubMed     Abstract available


    August 2019
  41. DEEDWANIA P
    Emerging strategies for diabetes and cardiovascular disorders: Introduction and foreword.
    Prog Cardiovasc Dis. 2019 Aug 27. pii: S0033-0620(19)30109.
    PubMed    


  42. ACHARYA T, Deedwania P
    Cardiovascular outcome trials of the newer anti-diabetic medications.
    Prog Cardiovasc Dis. 2019 Aug 20. pii: S0033-0620(19)30106.
    PubMed     Abstract available


  43. GARG V, Verma S, Connelly K
    Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetes.
    Prog Cardiovasc Dis. 2019 Aug 2. pii: S0033-0620(19)30102.
    PubMed     Abstract available


  44. GODOY LC, Ko DT, Rao V, Farkouh ME, et al
    The Role of Coronary Artery Bypass Surgery Versus Percutaneous Intervention in Patients with Diabetes and Coronary Artery Disease.
    Prog Cardiovasc Dis. 2019 Aug 1. pii: S0033-0620(19)30101.
    PubMed     Abstract available


    July 2019
  45. LAVIE CJ
    Continuing with Good Statistics at Progress in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2019 Jul 11. pii: S0033-0620(19)30099.
    PubMed    


  46. NELSON AJ, Peterson ED, Pagidipati NJ
    Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes.
    Prog Cardiovasc Dis. 2019 Jul 10. pii: S0033-0620(19)30098.
    PubMed     Abstract available


  47. GUPTA M, Tummala R, Ghosh RK, Blumenthal C, et al
    An update on pharmacotherapies in diabetic dyslipidemia.
    Prog Cardiovasc Dis. 2019;62:334-341.
    PubMed     Abstract available


    May 2019
  48. BOB-MANUEL T, Jenkins JS, Morin DP
    Non-arrhythmic causes of sudden death: A comprehensive review.
    Prog Cardiovasc Dis. 2019;62:265-271.
    PubMed     Abstract available


    February 2019
  49. NAUMAN J, Nes BM, Zisko N, Revdal A, et al
    Personal activity intelligence (PAI): A new standard in activity tracking for obtaining a healthy cardiorespiratory fitness level and low cardiovascular risk.
    Prog Cardiovasc Dis. 2019 Feb 21. pii: S0033-0620(19)30039.
    PubMed     Abstract available


  50. KIRKHAM AA, Beaudry RI, Paterson DI, Mackey JR, et al
    Curing breast Cancer and killing the heart: A novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast Cancer.
    Prog Cardiovasc Dis. 2019 Feb 21. pii: S0033-0620(19)30034.
    PubMed     Abstract available


    January 2019
  51. KAMINSKY LA, Arena R, Ellingsen O, Harber MP, et al
    Cardiorespiratory Fitness and Cardiovascular Disease - the Past, Present, and Future.
    Prog Cardiovasc Dis. 2019 Jan 9. pii: S0033-0620(19)30002.
    PubMed     Abstract available


    November 2018
  52. OZEMEK C, Laddu DR, Lavie CJ, Claeys H, et al
    An Update on the Role of Cardiorespiratory Fitness, Structured Exercise and Lifestyle Physical Activity in Preventing Cardiovascular Disease and Health Risk.
    Prog Cardiovasc Dis. 2018 Nov 13. pii: S0033-0620(18)30220.
    PubMed     Abstract available


    July 2018
  53. AWERBACH JD, Krasuski RA, Camitta MGW
    Coronary Disease and Modifying Cardiovascular Risk in Adult Congenital Heart Disease Patients: Should General Guidelines Apply?
    Prog Cardiovasc Dis. 2018 Jul 21. pii: S0033-0620(18)30151.
    PubMed     Abstract available


  54. ELAGIZI A, Kachur S, Lavie CJ, Carbone S, et al
    An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2018 Jul 5. pii: S0033-0620(18)30130.
    PubMed     Abstract available


  55. BARRY VW, Caputo JL, Kang M
    The Joint Association of Fitness and Fatness on Cardiovascular Disease Mortality: A Meta-Analysis.
    Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30131.
    PubMed     Abstract available


  56. RUIZ JR, Martinez-Tellez B, Sanchez-Delgado G, Osuna-Prieto FJ, et al
    Role of Human Brown Fat in Obesity, Metabolism and Cardiovascular Disease: Strategies to Turn Up the Heat.
    Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30129.
    PubMed     Abstract available


  57. ORTEGA FB, Lavie CJ
    Introduction and Update on Obesity and Cardiovascular Diseases 2018.
    Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30137.
    PubMed    


    June 2018
  58. PICHE ME, Poirier P, Lemieux I, Despres JP, et al
    Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update.
    Prog Cardiovasc Dis. 2018 Jun 28. pii: S0033-0620(18)30122.
    PubMed     Abstract available


  59. ENGLISH WJ, Williams DB
    Metabolic and Bariatric Surgery: An Effective Treatment Option for Obesity and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 Jun 25. pii: S0033-0620(18)30121.
    PubMed     Abstract available


    May 2018
  60. CHIAVAROLI L, Nishi SK, Khan TA, Braunstein CR, et al
    Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-Analysis of Controlled Trials.
    Prog Cardiovasc Dis. 2018 May 25. pii: S0033-0620(18)30094.
    PubMed     Abstract available


  61. KAHLEOVA H, Levin S, Barnard ND
    Vegetarian Dietary Patterns and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 May 22. pii: S0033-0620(18)30087.
    PubMed     Abstract available


  62. BITOK E, Sabate J
    Nuts and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 May 22. pii: S0033-0620(18)30092.
    PubMed     Abstract available


  63. SIEVENPIPER JL, Lavie CJ
    Dietary Prevention of Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2018 May 4. pii: S0033-0620(18)30085.
    PubMed    


    April 2018
  64. SALAS-SALVADO J, Becerra-Tomas N, Garcia-Gavilan JF, Bullo M, et al
    Mediterranean Diet and Cardiovascular Disease Prevention: What do We Know?
    Prog Cardiovasc Dis. 2018 Apr 17. pii: S0033-0620(18)30074.
    PubMed     Abstract available


  65. KIM ESH, Beckman JA
    Introduction to the Vascular Medicine Issue of Progress in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2018 Apr 6. pii: S0033-0620(18)30069.
    PubMed    


  66. AGRAWAL V, Kim ESH
    Spontaneous Coronary Artery Dissection: Cardiac Manifestations of Vascular Disease.
    Prog Cardiovasc Dis. 2018 Apr 6. pii: S0033-0620(18)30067.
    PubMed     Abstract available


    March 2018
  67. ELAGIZI A, Lavie CJ, Marshall K, DiNicolantonio JJ, et al
    Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health: A Comprehensive Review.
    Prog Cardiovasc Dis. 2018 Mar 20. pii: S0033-0620(18)30061.
    PubMed     Abstract available


    February 2018
  68. KERNEIS M, Talib U, Nafee T, Daaboul Y, et al
    Triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Prog Cardiovasc Dis. 2018 Feb 2. pii: S0033-0620(18)30028.
    PubMed     Abstract available


    January 2018
  69. EFFRON MB, Gibson CM
    The waxing and waning of antithrombotic therapy in cardiovascular disease - Where is the moon now?
    Prog Cardiovasc Dis. 2018 Jan 21. pii: S0033-0620(18)30032.
    PubMed    


  70. DINICOLANTONIO JJ, Liu J, O'Keefe JH
    Thiamine and cardiovascular disease: A literature review.
    Prog Cardiovasc Dis. 2018 Jan 19. pii: S0033-0620(18)30029.
    PubMed     Abstract available


  71. TANTRY U, Navarese EP, Myat A, Gurbel P, et al
    Selection of P2Y12 inhibitor in percutaneous coronary intervention and/or acute coronary syndrome.
    Prog Cardiovasc Dis. 2018 Jan 12. pii: S0033-0620(18)30020.
    PubMed     Abstract available


  72. ZEITOUNI M, Kerneis M, Nafee T, Collet JP, et al
    Anticoagulation in acute coronary syndrome-state of the art.
    Prog Cardiovasc Dis. 2018 Jan 12. pii: S0033-0620(18)30021.
    PubMed     Abstract available


  73. VIDULA MK, Secemsky EA, Yeh RW
    Duration of Dual Antiplatelet Therapy for Stented Patients: An Update for the Clinician.
    Prog Cardiovasc Dis. 2018;60.
    PubMed     Abstract available


  74. EFFRON MB, Gibson CM
    Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience.
    Prog Cardiovasc Dis. 2018;60.
    PubMed     Abstract available


  75. GOLWALA H, Bhatt DL
    The Timing of P2Y12 Inhibitor Initiation in the Treatment of ACS? Does the Evidence Exist in This Era?
    Prog Cardiovasc Dis. 2018;60.
    PubMed     Abstract available


    December 2017
  76. SARBACKER GB, Lusk KA, Kalich B
    Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease in Adults 80-Years-of-Age and Older.
    Prog Cardiovasc Dis. 2017 Dec 29. pii: S0033-0620(17)30168.
    PubMed    


  77. MOON JY, Franchi F, Rollini F, Angiolillo DJ, et al
    Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy.
    Prog Cardiovasc Dis. 2017 Dec 29. pii: S0033-0620(17)30166.
    PubMed     Abstract available


  78. SHARMA A, Garg A, Elmariah S, Drachman D, et al
    Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Prog Cardiovasc Dis. 2017 Dec 22. pii: S0033-0620(17)30165.
    PubMed     Abstract available


    November 2017
  79. KARIO K, Tomitani N, Kanegae H, Yasui N, et al
    Development of a New ICT-Based Multisensor Blood Pressure Monitoring System for Use in Hemodynamic Biomarker-Initiated Anticipation Medicine for Cardiovascular Disease: The National IMPACT Program Project.
    Prog Cardiovasc Dis. 2017 Nov 3. pii: S0033-0620(17)30142.
    PubMed     Abstract available


    September 2017
  80. HERMAN ME, O'Keefe JH, Bell DSH, Schwartz SS, et al
    Insulin Therapy Increases Cardiovascular Risk: Time for a Sea of Change in Type 2 Diabetes Treatment.
    Prog Cardiovasc Dis. 2017 Sep 25. pii: S0033-0620(17)30139.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: